These side effects are usually mild to moderate and often improve over time
But if the drug is anti-inflammatory and shes on a cancer medication that targets her immune system, he wondered, is that going to interfere with her therapy? No one knows
Nick Gennari, FedEx's president of healthcare, said, "We're building end-to-end solutions focused on global pharma customers, and what's so important with global pharma is that you have to recognize that there's a patient at the end of every delivery or someone that's waiting to be treated
For the regulatory landscape, see FDA peptide crackdown 2026
Early data suggests that while weight loss is aggressive, lean mass loss may not be disproportionately higher than existing medications, a key concern for athletes and high performers
And when retatrutide does hit the market (fingers crossed for 2026!), DT Peptides plans to offer it as part of our weight loss toolkit